Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

William A Richards

28 indexed publications match this author name.

ORCID: 0000-0003-0730-9249
OpenAlex: https://openalex.org/A5135688075

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Mystical Experience 9 Spirituality 8 Depression 7 Clinical Trial 6 Safety 6 Observational Study 5 Anxiety 5 Addiction 4 Healthcare Workers 4 Wellbeing 4 Receptor Pharmacology 4 Healthy Volunteers 3

Journals

Journal of psychopharmacology (Oxford, England) 4 The international journal of neuropsychopharmacology 2 PsyArXiv 2 Journal of palliative medicine 2 Psychopharmacology 2 Repository for Publications and Research Data (ETH Zurich) 1 Religion Brain & Behavior 1 Neuroscience Applied 1

Publication history

High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01 Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30 Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31 Electrical brain changes following psilocybin administration in sprague-dawley ratsNeuroscience Applied · 2026-01-01 The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-22 Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01 Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28 Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02 317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATSThe international journal of neuropsychopharmacology · 2025-08-01 363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIORThe international journal of neuropsychopharmacology · 2025-08-01 Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.Annual review of medicine · 2025-01-01 The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22 The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22 Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer · 2024-04-01 Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01 Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.JAMA oncology · 2023-06-01 Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-08-01 Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-19 Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in psychiatry · 2021-01-01 Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.Expert review of clinical pharmacology · 2020-08-01 Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.International review of psychiatry (Abingdon, England) · 2018-08-01 Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of psychopharmacology (Oxford, England) · 2018-01-01 Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01 Psychedelic Psychotherapy: Insights From 25 Years of ResearchJournal of Humanistic Psychology · 2016-09-29 Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-12-01 Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.Journal of psychopharmacology (Oxford, England) · 2008-08-01 The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by PsilocybinArchive for the Psychology of Religion · 2008-01-01 Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.Psychopharmacology · 2006-08-01

Author directory